Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience | Zendy

Alessandra Mangia | Zendy; Valeria Piazzolla | Zendy; Anna Giannelli | Zendy; Egidio Visaggi | Zendy; Nicola Minerva | Zendy; Vincenzo Ostilio Palmieri | Zendy; I. Carraturo | Zendy; Domenico Potenza | Zendy; Nicola Napoli | Zendy; Gianfranco Lauletta | Zendy; Vincenzo Tagarielli | Zendy; Rosanna Santoro | Zendy; Ernesto Piccigallo | Zendy; Sergio de Gioia | Zendy; Angelo Chimenti | Zendy; Giuseppe Cuccorese | Zendy; Antonio Metrangolo | Zendy; Michele Mazzola | Zendy; Ernesto Agostinacchio | Zendy; Giuseppe Mennea | Zendy; Carlo Sabbà | Zendy; Marina Cela | Zendy; Massimiliano Copetti | Zendy; R. Losappio | Zendy

Open Access

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

Author(s) -

Alessandra Mangia,

Valeria Piazzolla,

Anna Giannelli,

Egidio Visaggi,

Nicola Minerva,

Vincenzo Ostilio Palmieri,

I. Carraturo,

Domenico Potenza,

Nicola Napoli,

Gianfranco Lauletta,

Vincenzo Tagarielli,

Rosanna Santoro,

Ernesto Piccigallo,

Sergio de Gioia,

Angelo Chimenti,

Giuseppe Cuccorese,

Antonio Metrangolo,

Michele Mazzola,

Ernesto Agostinacchio,

Giuseppe Mennea,

Carlo Sabbà,

Marina Cela,

Massimiliano Copetti,

R. Losappio

Publication year - 2019

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0223287

Subject(s) - sofosbuvir , medicine , stage (stratigraphy) , fibrosis , gastroenterology , virology , biology , hepatitis c virus , ribavirin , virus , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research